Oncolytic activity of HF10 in head and neck squamous cell carcinomas

Recent developments in therapeutic strategies have improved the prognosis of head and neck squamous cell carcinoma (HNSCC). Nevertheless, 5-year survival rate remains only 40%, necessitating new therapeutic agents. Oncolytic virotherapy entails use of replication-competent viruses to selectively kil...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Gene Ther
Hoofdauteurs: Esaki, Shinichi, Goshima, Fumi, Ozaki, Haruka, Takano, Gaku, Hatano, Yoshimi, Kawakita, Daisuke, Ijichi, Kei, Watanabe, Takahiro, Sato, Yoshitaka, Murata, Takayuki, Iwata, Hiromitsu, Shibamoto, Yuta, Murakami, Shingo, Nishiyama, Yukihiro, Kimura, Hiroshi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group US 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445880/
https://ncbi.nlm.nih.gov/pubmed/31477804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-019-0129-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items